SEC Form 4 reporting owner

Lynch Ryan

Lynch Ryan has filed 5 Form 4 transactions reported between December 15, 2025 and September 16, 2026, as a reporting owner of CRESCENT BIOPHARMA, INC..

Name as filed: Lynch Ryan

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$13K
2 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 16, 2026
transaction date

Roles and reported holdings

  • CBIOCRESCENT BIOPHARMA, INC.
    Dec 15, 2025 – Sep 16, 2026

    Reporting owner

    Held directly13,631 sh as of Sep 16, 2026 · Form 4

    24 months: $13K sold

Transaction history

All 5 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 16, 2026CBIOOpen-market saleCode S · direct240$4K@ $17.90Form 4
Jun 22, 2026CBIOOpen-market saleCode S · direct465$8K@ $17.99Form 4
Dec 15, 2025CBIOGrant or awardCode A · direct33,512—Form 4
Dec 15, 2025CBIOGrant or awardCode A · direct4,000—Form 4
Dec 15, 2025CBIOGrant or awardCode A · direct8,378—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.